Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells — Stella

Home/Leigh Syndrome (Maternally Inherited, MILS)/Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

View on ClinicalTrials.gov

Recruiting

Back to Leigh Syndrome (Maternally Inherited, MILS) trials

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

Trial locations(2 sites)

Germany

Universitätsklinikum Düsseldorf, Düsseldorf, North Rhine-Westphalia

Charite - Universtaetsmedizin Berlin, Berlin, State of Berlin

Key details

Sponsor

Charite University, Berlin, Germany

Collaborators

European Union, German Research Foundation

Enrollment target

~80 participants

Started

March 2020

Primary completion

February 2030

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.